share_log

Context Therapeutics Q1 EPS $(0.23) Beats $(0.38) Estimate

Benzinga ·  May 8 18:00

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.38) by 39.47 percent. This is a 42.5 percent increase over losses of $(0.40) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment